TNFα mediates the skeletal effects of thyroid-stimulating hormone
暂无分享,去创建一个
Li Sun | M. Zaidi | T. Ando | T. Davies | E. Abe | L. Eldeiry | H. Hase | Alina Brebene | Yuanzhen Peng | Lanying Liu | H. Amano | Leslie S. Eldeiry
[1] E. Schwarz,et al. Tumor Necrosis Factor-α Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression* , 2006, Journal of Biological Chemistry.
[2] A. Zallone,et al. FSH Directly Regulates Bone Mass , 2006, Cell.
[3] Ying E. Zhang,et al. Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts* , 2006, Journal of Biological Chemistry.
[4] R. Pacifici,et al. The role of T lymphocytes in bone metabolism , 2005, Immunological reviews.
[5] E. Schwarz,et al. TNFα and pathologic bone resorption , 2005 .
[6] M. Zaidi. Neural surveillance of skeletal homeostasis. , 2005, Cell metabolism.
[7] P. Sexton,et al. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis , 2004, Leukemia.
[8] J. Franklyn,et al. A systematic approach to the assessment of known TNF-α polymorphisms in Graves' disease , 2004, Genes and Immunity.
[9] T. Graf,et al. Stepwise Reprogramming of B Cells into Macrophages , 2004, Cell.
[10] J. Compston,et al. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor α, interleukin 1, and receptor activator of nuclear factor κB ligand (RANKL) regulate osteoclasts , 2004 .
[11] Kwan Tat Steeve,et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .
[12] P. Santisteban,et al. TSH-activated signaling pathways in thyroid tumorigenesis , 2003, Molecular and Cellular Endocrinology.
[13] H. Uzun,et al. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism. , 2003, The Chinese journal of physiology.
[14] M. Nanes. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. , 2003, Gene.
[15] M. Zaidi,et al. TSH Is a Negative Regulator of Skeletal Remodeling , 2003, Cell.
[16] R. Pichler,et al. Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' disease. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[17] Z. Bolaman,et al. Proinflammatory cytokine levels in hyperthyroidism. , 2003, Clinical and investigative medicine. Medecine clinique et experimentale.
[18] P. Chambon,et al. Estradiol enhances primary antigen‐specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor α expression in hematopoietic cells , 2003, European journal of immunology.
[19] J. Klein,et al. An intrinsic thyrotropin-mediated pathway of TNF-alpha production by bone marrow cells. , 2003, Blood.
[20] J. Sanders,et al. Thyroid-stimulating monoclonal antibodies. , 2002, Thyroid : official journal of the American Thyroid Association.
[21] T. Ando,et al. A monoclonal thyroid-stimulating antibody. , 2002, The Journal of clinical investigation.
[22] Á. Hernanz,et al. Serum concentrations of tumour necrosis factor‐alpha (TNF‐α) and soluble TNF‐α receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function , 2002 .
[23] Terry Davies,et al. The TSH receptor reveals itself. , 2002, The Journal of clinical investigation.
[24] S. Schurmans,et al. The Role of Cyclic AMP and Its Effect on Protein Kinase A in the Mitogenic Action of Thyrotropin on the Thyroid Cell , 2002, Annals of the New York Academy of Sciences.
[25] M. Irahara,et al. Transient Increase in the Levels of T-Helper 1 Cytokines in Postmenopausal Women and the Effects of Hormone Replacement Therapy , 2001, Gynecologic and Obstetric Investigation.
[26] S. Wodak,et al. A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor* , 2001, The Journal of Biological Chemistry.
[27] D. Bauer,et al. Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone , 2001, Annals of Internal Medicine.
[28] M. Feldmann,et al. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.
[29] T. Kitamura,et al. Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.
[30] D. Forrest,et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. , 1999, Genes & development.
[31] J. Economou,et al. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. , 1992, The Journal of biological chemistry.
[32] M. Parmentier,et al. Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. , 1990, Biochemical and biophysical research communications.